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Edited by Thomas L. JamesAbstract During chemical denaturation diﬀerent intermediate
states are populated or suppressed due to the nature of the
denaturant used. Chemical denaturation by guanidine–HCl
(GuHCl) of human carbonic anhydrase II (HCA II) leads to a
three-state unfolding process (Cm;NI = 1:0 and Cm;IU = 1:9 M
GuHCl) with formation of an equilibrium molten-globule inter-
mediate that is stable at moderate concentrations of the
denaturant (1–2 M) with a maximum at 1.5 M GuHCl. On
the contrary, urea denaturation gives rise to an apparent two-
state unfolding transition (Cm =4:4 M urea). However, 8-
anilino-1-naphthalene sulfonate (ANS) binding and decreased
refolding capacity revealed the presence of the molten globule in
the middle of the unfolding transition zone, although to a lesser
extent than in GuHCl. Cross-linking studies showed the forma-
tion of moderate oligomer sized (300 kDa) and large soluble
aggregates (>1000 kDa). Inclusion of 1.5 M NaCl to the urea
denaturant to mimic the ionic character of GuHCl leads to a
three-state unfolding behavior (Cm;NI = 3:0 and Cm;IU = 6:4 M
urea) with a signiﬁcantly stabilized molten-globule intermediate
by the chloride salt. Comparisons between NaCl and LiCl of the
impact on the stability of the various states of HCA II in urea
showed that the eﬀects followed what could be expected from the
Hofmeister series, where Liþ is a chaotropic ion leading to
decreased stability of the native state. Salt addition to the
completely urea unfolded HCA II also led to an aggregation
prone unfolded state, that has not been observed before for
carbonic anhydrase. Refolding from this state only provided low
recoveries of native enzyme.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The mechanism by which a protein polypeptide chain
spontaneously folds to its native state is still a major goal to
solve for protein chemists. Current research has focused on the
role of folding intermediates or ensembles in reaching the na-
tive conformation. In this respect, the molten-globule inter-* Corresponding author. Fax: +46-13-281399.
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Abbreviations: ANS, 8-anilino-1-naphthalene sulfonic acid; GuHCl,
guanidine–HCl; HCA II, human carbonic anhydrase II
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doi:10.1016/j.febslet.2004.03.105mediate has been extensively studied both by equilibrium and
kinetic methods [1].
Folding studies of human carbonic anhydrase II (HCA II)
have revealed the existence of folding intermediates both at
equilibrium and kinetic conditions [2,3].
HCA II unfolds in two well-separated transitions when in-
cubated in increasing concentrations of guanidine–HCl (Gu-
HCl). This leads to the formation of a stable enzymatically
inactive folding intermediate at medium concentrations of the
denaturant [4,5]. Characterization of this intermediate has
shown that it is of molten-globule type. In addition, it has been
demonstrated that this molten globule is prone to aggregation
and impossible to reactivate upon dilution of the GuHCl de-
naturant. The formed aggregates from the molten globule are
soluble oligomers with a diameter of approximately 13.5 nm.
The aggregation site is very speciﬁc, and is located in the large
b-sheet of the protein, within a limited region between the
hydrophobic b-strands 4 and 7 [6]. During refolding of the
completely denatured protein, a molten-globule intermediate
transiently appears [7] and gives rise to a fraction of protein
that aggregates, which lowers the yield of native enzyme to
about 75% under optimal conditions [8–10]. However, the
chaperonin GroEL binds to the molten-globule intermediate
and protects it from aggregating during refolding, but cannot
rescue preformed aggregates [6,11].
In this report, we have studied how a non-ionic denaturant
as urea unfolds HCA II and what role chloride salts have on
this process. Surprisingly, urea denaturation leads to an ap-
parent two-state unfolding transition, although closer exami-
nation revealed minor formation of the molten-globule
intermediate also in this case. Moreover, it is shown that
chloride ions markedly stabilizes this molten globule that
thereby promotes self-assembly into various oligomeric states.2. Materials and methods
2.1. Chemicals
Urea and LiCl were purchased from Merck and the urea concen-
tration was determined by refractive index [12]. 8-Anilino-1-naphtha-
lene sulfonic acid (ANS) was obtained from Sigma and GuHCl from
Pierce. All other chemicals were of reagent grade.
2.2. Protein production and puriﬁcation
The cysteine-free C206S pseudo wild-type type of HCA II was ex-
pressed from BL21/DE3 Escherichia coli. Protein production and















































Fig. 1. Stability and molten-globule formation in urea and urea+
1.5 M NaCl. (A) Global unfolding measured by Trp ﬂuorescence
emission peak of HCA II (0.025 mg/ml) following excitation at 295 nm.
Open circles show data from HCA II incubated in urea and ﬁlled
circles show data from incubation in urea+ 1.5 M NaCl. The data were
96 K. Boren et al. / FEBS Letters 566 (2004) 95–99have previously shown that the pseudo wild-type has properties that
are indistinguishable from those of the wild-type of HCA II [4].
2.3. Stability measurements
The unfolding proﬁle of HCA II was determined by intrinsic Trp
ﬂuorescence measurements as previously described [14]. Before mea-
surements, the enzyme was incubated for 24 h at 23 C in freshly made
urea solutions (up to 8 M) with and without NaCl or LiCl (1.5 M)
buﬀered with 10 mM Na-phosphate, pH 7.5.
The stability data were analyzed by a non-linear least-square ﬁtting
equation through linear extrapolation to 0 M of denaturant as de-
scribed by Santoro and Bolen [15], using the program TableCurve 2D
(Jandel Scientiﬁc). The midpoint concentration of denaturation, Cm, of
each unfolding transition and the free energy of unfolding in water
DGH2O were determined as previously reported [16].
2.4. ANS binding
The binding of ANS to protein in its molten-globule state [17,18] was
examined by incubation of protein (0.025 mg/ml; 0.83 lM) at various
concentrations of urea with and without NaCl or LiCl (1.5 M) in 10
mM Na-phosphate buﬀer, pH 7.5, with an 80-fold molar excess of
ANS present for 24 h at 23 C. Fluorescence emission spectra were
recorded between 450 and 650 nm and the intensity at emission
maximum of the samples was plotted as a function of urea concen-
tration. The samples were excited at 360 nm, and excitation and
emission bandwidths were 5 and 10 nm, respectively. The cuvette
length was 1 cm and the spectroﬂuorimeter was thermostated at 23 C.
2.5. Chemical cross-linking
The used glutaraldehyde cross-linking protocol was used essentially
as that described for transthyretin [19].
Samples of HCA II (0.20 mg/ml) were incubated for about 24 h in
diﬀerent concentrations of urea, in the presence of 0, and 1.5 M NaCl
(or in 1.5 M GuHCl) in 10 mM Na-phosphate buﬀer, pH 7.5. Glu-
taraldehyde (25%, 100 ll) was added to 1.0 ml of the HCA II solution
and the cross-linking reaction was allowed to proceed for 4 min before
the reaction was quenched by addition of 100 ll of NaBH4 (7% in 0.1
M NaOH). The cross-linked protein samples were desalted using a
PD10 column (Amersham Biosciences) in water and were thereafter
mixed with reducing SDS cocktail (ﬁnal SDS concentration was 2.5%).
The samples were boiled for 5 min before loading onto a SDS–PAGE
gel. The protein bands were stained with Coomassie, scanned and
quantiﬁed by use of the program Scion Image (Scion Corp.).ﬁtted to a single or double transition for HCA II unfolded in urea or in
urea+ 1.5 M NaCl, respectively. (B) ANS binding to probe for the
formation of molten globules. ANS was excited at 360 nm and the
emission intensity at 480 nm was recorded. The intensity was corrected
from reference samples in the corresponding concentrations of urea or
urea+ 1.5 M NaCl, respectively. Open circles show data from HCA II
incubated in urea and ﬁlled circles show data from incubation in
urea+ 1.5 M NaCl. (C) Refolding yield of HCA II after incubation in
various concentrations of urea. Reactivation of the enzyme was initi-
ated through dilution of the denaturant to 1.0 M urea and 0.025 mg/ml
HCA II following 24 h incubation at the urea concentrations indicated
on the x-axis (at 0.25 mg/ml). Incubation was performed in urea alone
(open circles) or in urea+ 1.5 M NaCl (ﬁlled circles).3. Results and discussion
3.1. Less formation of molten globule by urea than by GuHCl
denaturation
The stability of HCA II towards urea denaturation, as
monitored by the change in intrinsic Trp ﬂuorescence, is shown
in Fig. 1A. Contrary to GuHCl-induced unfolding the protein
seems to be unfolded in a two-state process without presence
of an intermediate state with a mid-point concentration of
unfolding ðCmÞ at 4.4 M urea. Notably, urea unfolding of
bovine carbonic anhydrase II (BCA II) did not lead to any
detectable equilibrium intermediates, whereas denaturation by
GuHCl gave rise to several unfolding intermediates [20]. The
magnitude of the ﬂuorescence red-shift indicates that HCA II
is denatured to the globally unfolded state [21]. The calculated
free energy ðDGH2OÞ of the N$U transition is 19.0 kcal/mol,
which is very similar to the summed free energies (18.7 kcal/
mol) of the GuHCl-mediated transitions (N$ I$U) [4]. This
also supports the notion that the protein is unfolded to the
same degree by the two denaturants.
In the transition zone some binding of the hydrophobic
probe ANS is noted, indicating that minor formation of the
molten-globule intermediate also occurs during urea denatur-
ation (Fig. 1B). In comparison BCA II did not show any ANSbinding in the range 0–8 M urea [20]. Previously, we have
observed that the molten-globule intermediate of HCA II is
prone to aggregation at equilibrium conditions. Thus, if HCA
II is denatured at GuHCl concentrations promoting the mol-
ten-globule state (1–2 M) the recovery of active enzyme upon
dilution of the denaturant is drastically reduced. This is due to
irreversibly formed self-assembled aggregates by the molten-
globule intermediates [6]. Denaturation by urea concentrations
(4–5 M) leading to some ANS binding also gives rise to sig-
niﬁcantly decreased refolding yields (40%) upon renaturation
under optimal conditions (i.e., dilution to 1 M urea [22]
(Fig. 1C), although not to such low yields as for GuHCl
(10%) [6]). Together the ANS and refolding experiments
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also is induced by moderate concentrations of urea, but to a
lesser extent than for GuHCl. In addition, cross-linking ex-
periments show that this molten globule, formed at 4.5 M
urea, is highly prone to aggregate, with a major fraction giving
a strong 300 kDa SDS–PAGE band corresponding to ap-
proximately decameric sized aggregates. Moreover, a consid-
erable fraction forms very large aggregates (>1000 kDa), seen
as a protein band that has not been able to leave the concen-
tration gel (Fig. 2, lane 3).
Under optimal denaturation and renaturation conditions,
i.e., at 8 and 1 M urea, respectively, a reactivation yield of
about 90% can be achieved. This is somewhat higher than can
be obtained after GuHCl renaturation (about 75%) [11], in-
dicating that the kinetic molten-globule, that seems to cause
aggregation, also is suppressed in urea. However, complete
reactivation is not obtained, probably due to formation of a
minor fraction of aggregates of relatively small size evident
from ‘‘smeared’’ bands (60–300 kDa) in the cross-linking
analysis of HCA II in 7 M urea (Fig. 2, lane 5).
3.2. Salt eﬀects on the conformational states of HCA II during
urea unfolding
Since urea is a non-ionic denaturant and GuHCl is ionic
containing Cl as counter ions, it is of interest to investigate
the addition of Cl containing salts to urea to understand the
diﬀerence in unfolding behavior of HCA II by the two dena-
turants. Since 1.5 M GuHCl leads to maximal formation of the
aggregation-prone molten-globule form according to ANS and
reactivation data [6], we included 1.5 M Cl in the urea so-
lutions to mimic the ionic character of GuHCl either by ad-
dition of NaCl or LiCl.
3.3. NaCl addition stabilizes the molten globule
Addition of 1.5 M NaCl to varying concentrations of urea
transforms the equilibrium unfolding of HCA II to a clear
three-state unfolding process (N$ I$U), as monitored by
Trp ﬂuorescence measurements (Fig. 1A) with a proﬁle that is
very similar to that induced by GuHCl [6]. ANS binding to this
intermediate is, similar to the GuHCl-induced intermediate
[23], profound and is dramatically increased by the addition of
NaCl to the urea denaturant (Fig. 1B). Furthermore, this in-
termediate is almost totally impossible to reactivate upon di-
lution to refolding conditions (Fig. 1C). Thus, it exhibits all theFig. 2. SDS–PAGE gel of cross-linked protein. HCA II (0.2 mg/ml)
was incubated (24 h, 23 C) in various denaturants buﬀered with 10
mM phosphate buﬀer (pH 7.5) prior to 4 min of glutaraldehyde cross-
linking. Lane 1: Native protein no denaturant; Lane 2: 1.5 M GuHCl;
Lane 3: 4.5 M urea; Lane 4: 4.5 M urea+ 1.5 M NaCl; Lane 5: 7 M
urea; Lane 6: 7 M urea+ 1.5 M NaCl.characteristics that are typical for the molten-globule state of
HCA II. Cross-linking performed on the protein (in 4.5 M
urea+ 1.5 M NaCl) demonstrates that the molten globule
forms aggregates to a larger extent than in the absence of salt
(Fig. 2, lane 4) leaving only 20% of the protein in monomeric
form. Some diﬀerences are obvious regarding the distribution
of aggregate sizes. Thus, much less oligomeric 300 kDa ag-
gregates and more of the very large aggregate type are formed
than in urea without added salt. In 1.5 M GuHCl no mono-
mers remain, but >95% decameric self-assembled oligomers
(300 kDa) are formed with <5% in large aggregates, indicating
that GuHCl makes the molten globule self-assembly more
monodisperse (Fig. 2, lane 2).
The presence of NaCl stabilizes the aggregation prone
molten globule at the expense of the native (N) and the un-
folded (U) states, since the N$ I transition is shifted from 4.4
to 3.0 M urea and the I$U transitions from 4.4 to 6.4 M
urea. For acid-unfolded cytochrome c and apomyoglobin an-
ions have been shown to stabilize molten globules by reduction
of the net positive charge on the protein through anion binding
[24]. Anion shielding by chloride of local repulsive positive
charges can dramatically stabilize quaternary structures which
was demonstrated for transthyretin [19]. At pH 7.5 HCA II has
almost no net charge, since the pI is 7.3 [25]. However, the
HCA II molecule contains several tertiary ionic interactions.
Therefore, speciﬁc anion binding could have signiﬁcant eﬀects
in breaking tertiary interactions in the native conformation,
and thereby destabilize the native state. On the other hand,
Debye shielding of ﬂuctuating positively charged side chains in
the molten-globule intermediate can have a stabilizing eﬀect in
that it reduces charge repulsion between these groups. More-
over, increased ionic strength will strengthen the hydrophobic
eﬀect, which also will favor the molten-globule state over the
unfolded state. Previously, we have demonstrated that the
molten-globule forms aggregates in a very speciﬁc way medi-
ated by hydrophobic interaction [6].
Presence of NaCl at high concentrations of urea (>7 M)
appears to induce a globally unfolded protein (U) according to
Trp emission maximum (353 nm) [21] and low ANS binding
(Fig. 1A and B), nevertheless only modest degrees of reacti-
vation (15–30%) could be achieved from these U-states
(Fig. 1C). The lowered yield of reactivateable enzyme is also in
this case due to aggregation of the unfolded protein chain. The
cross-linking experiment performed on protein incubated in 7
M urea with 1.5 M NaCl shows that a high proportion of the
protein forms aggregates of varying sizes with predominance
of very large aggregates (Fig. 2, lane 6). This is the ﬁrst time
that carbonic anhydrase has been observed to aggregate in the
unfolded state, which seems to be promoted by an increased
hydrophobic eﬀect from NaCl. This clustering could originate
from the hydrophobic residues in the central core of HCA II
that evidently can be solubilized by 5 M GuHCl but not by 7
M urea containing 1.5 M NaCl.
3.4. Eﬀects of LiCl
The eﬀects on urea denaturation of HCA II by addition of
LiCl might shed some light on the mechanism by which Cl
and the counter ion inﬂuence the stability of the various states
of HCA II. According to the Hofmeister series, Liþ is a more
salting-in cation than Naþ and consequently expected to be
more denaturing. As seen in Fig. 3A, the native state is also
even more destabilized in the presence of LiCl than with NaCl
N I U
O Agg
Fig. 4. Cartoon showing the folding and misfolding pathways for HCA
II that is greatly inﬂuenced by the denaturant used. N, native protein;
I, molten-globule intermediate; U, unfolded protein; O, oligomeric
(majority is decameric) self-assembled molten globules; Agg, large












































Fig. 3. Stability and molten-globule formation in urea+ 1.5 M LiCl.
(A) Global unfolding measured by Trp ﬂuorescence emission peak of
HCA II (0.025 mg/ml) following excitation at 295 nm. The data were
ﬁtted to a double transition. (B) ANS binding to probe for formation
of molten globules. ANS was excited at 360 nm and the emission
intensity at 480 nm was recorded. The intensity was corrected from
reference samples in the corresponding concentrations of urea+ 1.5 M
LiCl. (C) Refolding yield of HCA II after incubation in various con-
centrations of urea+1.5 LiCl. Reactivation of the enzyme was initiated
through dilution of the denaturant to 1.0 M urea and to 0.025 mg/ml
HCA II following 22 h incubation at the urea concentrations indicated
on the x axis (at 0.25 mg/ml).
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at 3.9 M urea, thus Liþ increases the denaturing eﬀect of urea
compared to Naþ by improving solvation of exposed hydro-
phobic and peptide groups in the unfolded state as predicted
from the lyotropic or Hofmeister series [26–30]. Furthermore,
the total stability of HCA II in 1.5 M LiCl, calculated for the
two unfolding transitions (N$ I$U) and extrapolated to 0
M urea, is only 10.5 kcal/mol compared to 19.0 kcal/mol in the
absence of LiCl, i.e., in water. The corresponding stability in
1.5 M NaCl is 21.2 kcal/mol. This clearly indicates that Liþ has
a destabilizing eﬀect on the protein, whereas Naþ does not
signiﬁcantly aﬀect the global stability. However, it should be
pointed out that the ﬁgures above do not represent true
equilibrium values, since irreversible aggregation also occurs.
Nevertheless, these values give at least qualitative information
supporting the conclusions drawn above.
The unfolding intermediate, found at 2–3 M urea with 1.5 M
LiCl, binds ANS (Fig. 3B) and is practically impossible to re-activate (Fig. 3C), which means that in the presence of LiCl also
an aggregation prone molten globule is formed. Notably, ANS
binding even occurs in the N$ I pre-transition zone, indicating
that the native conformation becomes more ﬂexible exposing
otherwise buried hydrophobic patches due to the decreased
hydrophobic interaction caused by LiCl. This is also evident
from the reactivation measurements. At high urea concentra-
tions with LiCl no reactivation of globally unfolded protein
(kmax = 352 nm for Trp ﬂuorescence) can be obtained (Fig. 3C),
indicating that LiCl like NaCl in urea leads to the formation of
stable aggregates. In the reactivation and cross-linking experi-
ments, the protein was incubated at higher concentrations (0.25
and 0.20 mg/ml, respectively) than in the corresponding Trp
ﬂuorescence and ANS experiments (0.025 mg/ml) and a visible
precipitate of the protein was in fact observed from samples at
high urea concentrations (7 M), showing that the protein is
undergoing aggregation. Accordingly, cross-linking experi-
ments were spoiled due to precipitation of very large aggregates.
Together it is evident that addition of LiCl to urea makes the U
state of HCA II even more prone to aggregate than NaCl does.
This was highly surprising since LiCl was expected to resemble
GuHCl more than NaCl.
3.5. Conclusions
The scheme in Fig. 4 summarizes the folding and misfolding
pathways for HCA II. The ionic character of the denaturants
markedly aﬀects the stability of the molten-globule interme-
diate in HCA II and inﬂuences the self-assembly properties of
the partially unfolded protein. Promoting the formation of the
aggregation-prone molten-globule intermediate by the pres-
ence of chloride salts favors self-assembly into misfolded
oligomeric structures that cannot be refolded. Furthermore,
the ionic eﬀect strengthens the hydrophobic interaction re-
sulting in increased association in the urea-unfolded state into
large aggregates.
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